| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
159,420 |
127,634 |
$18.92M |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
102,555 |
80,252 |
$14.70M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
45,586 |
34,850 |
$3.09M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26,269 |
17,079 |
$981K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
57,640 |
56,964 |
$867K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19,909 |
11,836 |
$809K |
| 84443 |
Thyroid stimulating hormone (TSH) |
83,517 |
82,360 |
$753K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
8,858 |
8,003 |
$694K |
| 80061 |
Lipid panel |
87,723 |
86,610 |
$626K |
| 80053 |
Comprehensive metabolic panel |
101,929 |
99,701 |
$617K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
100,870 |
97,999 |
$443K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
18,625 |
18,257 |
$385K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18,626 |
18,248 |
$370K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
69,017 |
68,141 |
$322K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
20,805 |
20,587 |
$291K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
3,021 |
2,969 |
$284K |
| 82607 |
|
31,980 |
31,622 |
$255K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
5,953 |
5,830 |
$237K |
| 80074 |
|
8,296 |
8,195 |
$214K |
| 84439 |
|
42,418 |
41,790 |
$210K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
11,717 |
11,370 |
$206K |
| 87536 |
|
3,919 |
3,883 |
$196K |
| 84403 |
|
12,751 |
12,515 |
$191K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
11,535 |
11,387 |
$185K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
7,724 |
7,682 |
$165K |
| 84153 |
|
16,242 |
16,001 |
$158K |
| 82728 |
|
18,165 |
17,855 |
$130K |
| 87481 |
|
4,340 |
3,859 |
$128K |
| 86803 |
|
15,385 |
15,208 |
$117K |
| 84481 |
|
10,321 |
10,167 |
$101K |
| 86235 |
|
2,454 |
1,749 |
$98K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
20,454 |
19,676 |
$91K |
| 83970 |
|
3,996 |
3,930 |
$91K |
| 86769 |
|
3,101 |
3,019 |
$90K |
| 87522 |
Neg quan hep c or qual rna |
3,255 |
3,206 |
$88K |
| 82670 |
|
5,440 |
5,367 |
$86K |
| 82746 |
|
10,417 |
10,318 |
$84K |
| 36415 |
Collection of venous blood by venipuncture |
54,232 |
51,431 |
$83K |
| 83540 |
|
21,809 |
21,421 |
$76K |
| 83001 |
|
6,286 |
6,196 |
$67K |
| 83550 |
|
14,929 |
14,691 |
$67K |
| 86696 |
|
4,774 |
4,680 |
$67K |
| 83013 |
|
1,847 |
1,819 |
$66K |
| 83735 |
|
18,378 |
17,881 |
$66K |
| 84702 |
|
8,154 |
7,265 |
$59K |
| 84146 |
|
5,216 |
5,151 |
$59K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,039 |
2,965 |
$56K |
| 83002 |
|
5,267 |
5,198 |
$56K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,691 |
11,416 |
$54K |
| 83880 |
|
2,342 |
2,288 |
$49K |
| 80076 |
|
13,360 |
11,854 |
$47K |
| 84100 |
|
18,108 |
14,754 |
$43K |
| 84144 |
|
3,592 |
3,454 |
$42K |
| 82043 |
|
13,279 |
13,110 |
$42K |
| 87088 |
|
8,822 |
8,590 |
$41K |
| 86038 |
|
5,618 |
5,525 |
$38K |
| 84480 |
|
4,776 |
4,714 |
$37K |
| 84550 |
|
15,819 |
15,592 |
$37K |
| 87340 |
|
6,937 |
6,856 |
$36K |
| 86780 |
|
4,399 |
4,368 |
$36K |
| 86695 |
|
3,888 |
3,814 |
$36K |
| 84460 |
|
12,613 |
10,818 |
$36K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
156 |
150 |
$35K |
| 86361 |
|
2,677 |
2,661 |
$35K |
| 84450 |
|
12,493 |
10,698 |
$35K |
| 88307 |
|
201 |
197 |
$34K |
| 82652 |
|
1,767 |
1,757 |
$34K |
| 84154 |
|
3,332 |
3,275 |
$33K |
| 86480 |
|
939 |
931 |
$32K |
| 81001 |
|
19,005 |
18,358 |
$31K |
| 86481 |
|
548 |
543 |
$31K |
| 87077 |
|
6,267 |
6,101 |
$30K |
| 82784 |
|
2,469 |
2,181 |
$30K |
| 86376 |
|
3,434 |
3,363 |
$29K |
| 87070 |
|
5,440 |
5,335 |
$29K |
| 87186 |
|
5,808 |
5,518 |
$29K |
| 86592 |
|
11,133 |
11,025 |
$27K |
| 85027 |
|
7,433 |
7,314 |
$26K |
| 82627 |
|
2,099 |
2,069 |
$26K |
| 82570 |
|
9,523 |
8,687 |
$26K |
| 84075 |
|
8,519 |
6,781 |
$23K |
| 86141 |
|
3,147 |
3,064 |
$22K |
| 87563 |
|
985 |
966 |
$22K |
| 86706 |
|
3,398 |
3,350 |
$21K |
| 86800 |
|
2,274 |
2,239 |
$21K |
| 82040 |
|
7,826 |
6,129 |
$20K |
| 84165 |
|
3,263 |
3,165 |
$18K |
| 80069 |
|
3,716 |
3,603 |
$18K |
| 82378 |
|
1,837 |
1,627 |
$17K |
| 86225 |
|
2,199 |
2,119 |
$17K |
| 83525 |
|
2,401 |
2,378 |
$16K |
| 84155 |
|
8,282 |
6,579 |
$16K |
| 83690 |
|
4,019 |
3,941 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
462 |
195 |
$16K |
| 82533 |
|
1,685 |
1,539 |
$15K |
| 82247 |
|
5,587 |
4,581 |
$15K |
| 82550 |
|
4,480 |
4,396 |
$15K |
| 82947 |
|
6,923 |
6,843 |
$14K |
| 83020 |
|
1,874 |
1,856 |
$14K |
| 83521 |
|
932 |
811 |
$14K |
| 86787 |
|
1,765 |
1,748 |
$13K |
| 82565 |
|
5,204 |
5,088 |
$13K |
| 82977 |
|
3,265 |
3,157 |
$12K |
| 86762 |
|
1,636 |
1,618 |
$12K |
| 86431 |
|
3,541 |
3,479 |
$11K |
| 86708 |
|
1,501 |
1,482 |
$11K |
| 83615 |
|
3,668 |
3,465 |
$11K |
| 80050 |
General health panel |
5,554 |
5,485 |
$11K |
| 85652 |
|
7,592 |
7,426 |
$11K |
| 86334 |
|
993 |
968 |
$11K |
| 82248 |
|
3,576 |
3,524 |
$11K |
| 85610 |
|
4,771 |
4,173 |
$11K |
| 84238 |
|
634 |
621 |
$11K |
| 86704 |
|
1,526 |
1,504 |
$11K |
| 82150 |
|
2,859 |
2,804 |
$10K |
| 86140 |
|
3,671 |
3,553 |
$10K |
| 80164 |
|
1,315 |
1,281 |
$10K |
| 84436 |
|
2,806 |
2,775 |
$10K |
| 80051 |
|
2,606 |
2,541 |
$10K |
| 84520 |
|
4,681 |
4,581 |
$9K |
| 83516 |
|
891 |
805 |
$9K |
| 82105 |
|
1,110 |
1,084 |
$9K |
| 80055 |
|
326 |
325 |
$8K |
| 86850 |
|
1,499 |
1,489 |
$8K |
| 81003 |
|
6,656 |
6,473 |
$8K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
123 |
108 |
$7K |
| 83090 |
|
690 |
682 |
$7K |
| 86709 |
|
1,173 |
1,167 |
$6K |
| 85730 |
|
2,367 |
2,260 |
$6K |
| 86200 |
|
817 |
801 |
$6K |
| 86705 |
|
1,092 |
1,085 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
156 |
150 |
$6K |
| 82785 |
|
594 |
579 |
$5K |
| 81025 |
|
944 |
807 |
$5K |
| 82310 |
|
1,990 |
1,967 |
$5K |
| 84156 |
|
2,427 |
2,338 |
$5K |
| 85045 |
|
2,047 |
2,010 |
$4K |
| 85651 |
|
2,049 |
1,978 |
$4K |
| 84466 |
|
571 |
567 |
$4K |
| 84311 |
|
1,290 |
673 |
$4K |
| 88112 |
|
214 |
212 |
$4K |
| 87081 |
|
951 |
944 |
$4K |
| 86900 |
|
2,263 |
2,231 |
$3K |
| 86901 |
|
2,272 |
2,238 |
$3K |
| 84270 |
|
4,241 |
4,140 |
$3K |
| 86147 |
|
118 |
100 |
$3K |
| 87581 |
|
155 |
149 |
$3K |
| 86300 |
|
264 |
228 |
$3K |
| 0065U |
|
1,399 |
1,367 |
$2K |
| 87625 |
|
130 |
127 |
$2K |
| 80363 |
|
695 |
631 |
$2K |
| 80356 |
|
819 |
745 |
$2K |
| 80365 |
|
860 |
781 |
$2K |
| 80354 |
|
847 |
769 |
$2K |
| 87631 |
|
22 |
19 |
$2K |
| 80347 |
|
730 |
662 |
$2K |
| 99001 |
|
731 |
339 |
$2K |
| 80360 |
|
771 |
700 |
$2K |
| 84484 |
|
276 |
270 |
$2K |
| 82330 |
|
227 |
223 |
$2K |
| 80349 |
|
828 |
739 |
$2K |
| 86304 |
|
176 |
170 |
$2K |
| 83986 |
|
1,158 |
620 |
$2K |
| 83010 |
|
228 |
228 |
$2K |
| 80372 |
|
737 |
670 |
$2K |
| 83992 |
|
763 |
693 |
$2K |
| 80361 |
|
871 |
792 |
$2K |
| 82232 |
|
199 |
192 |
$1K |
| 80359 |
|
757 |
690 |
$1K |
| 84703 |
|
318 |
311 |
$1K |
| 80178 |
|
358 |
345 |
$1K |
| 88142 |
|
127 |
126 |
$1K |
| 86301 |
|
159 |
151 |
$1K |
| 85379 |
|
239 |
233 |
$1K |
| 80348 |
|
870 |
790 |
$1K |
| 80373 |
|
828 |
753 |
$1K |
| 80353 |
|
705 |
640 |
$1K |
| 80355 |
|
543 |
483 |
$1K |
| 86160 |
|
122 |
108 |
$1K |
| 80368 |
|
459 |
418 |
$1K |
| 80369 |
|
430 |
393 |
$994.00 |
| 82465 |
|
534 |
531 |
$919.65 |
| 80366 |
|
479 |
437 |
$882.00 |
| 86255 |
|
113 |
112 |
$797.56 |
| 80047 |
|
103 |
103 |
$790.38 |
| 85007 |
|
555 |
551 |
$740.79 |
| 80358 |
|
866 |
786 |
$725.26 |
| 83721 |
|
131 |
128 |
$708.44 |
| 84132 |
|
353 |
349 |
$644.82 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
98 |
97 |
$635.08 |
| 80367 |
|
381 |
348 |
$610.00 |
| 80325 |
|
211 |
195 |
$576.00 |
| 87660 |
|
43 |
42 |
$570.99 |
| 87480 |
|
43 |
42 |
$567.10 |
| 87510 |
|
43 |
42 |
$567.10 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
202 |
202 |
$547.60 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
55 |
54 |
$527.49 |
| 80346 |
|
22 |
20 |
$500.00 |
| 86146 |
|
12 |
12 |
$496.09 |
| 80345 |
|
470 |
429 |
$483.20 |
| 82951 |
|
53 |
53 |
$389.31 |
| 84295 |
|
132 |
132 |
$356.21 |
| 83014 |
|
83 |
81 |
$312.20 |
| 80324 |
|
504 |
466 |
$308.00 |
| 86618 |
|
24 |
24 |
$307.09 |
| 82668 |
|
25 |
25 |
$278.94 |
| 82435 |
|
99 |
99 |
$247.55 |
| 86765 |
|
42 |
42 |
$239.95 |
| 86665 |
|
15 |
15 |
$238.84 |
| 87255 |
|
15 |
15 |
$226.10 |
| 85060 |
|
189 |
186 |
$212.48 |
| 80362 |
|
22 |
20 |
$200.00 |
| 83883 |
|
58 |
56 |
$185.60 |
| 80323 |
|
76 |
68 |
$142.80 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
12 |
$139.68 |
| 82374 |
|
44 |
43 |
$123.75 |
| 84479 |
|
165 |
163 |
$121.80 |
| 80321 |
|
61 |
56 |
$100.00 |
| 86777 |
|
13 |
13 |
$90.52 |
| 84478 |
|
24 |
24 |
$63.25 |
| 80326 |
|
21 |
18 |
$49.00 |
| 82950 |
|
13 |
13 |
$36.30 |
| 80364 |
|
17 |
15 |
$32.00 |
| 81015 |
|
49 |
49 |
$30.74 |
| 86593 |
|
12 |
12 |
$30.40 |
| 80338 |
|
36 |
33 |
$28.00 |
| 80344 |
|
33 |
30 |
$18.00 |
| 80337 |
|
31 |
29 |
$15.00 |
| 80340 |
|
14 |
12 |
$12.00 |
| 80370 |
|
14 |
12 |
$12.00 |
| 80371 |
|
13 |
12 |
$10.00 |
| 80357 |
|
13 |
12 |
$10.00 |
| 80350 |
|
13 |
12 |
$10.00 |
| 0210U |
|
86 |
85 |
$0.00 |
| 80334 |
|
14 |
14 |
$0.00 |